Your browser doesn't support javascript.
loading
Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial.
Mamounas, Eleftherios P; Bandos, Hanna; Lembersky, Barry C; Jeong, Jong-Hyeon; Geyer, Charles E; Rastogi, Priya; Fehrenbacher, Louis; Graham, Mark L; Chia, Stephen K; Brufsky, Adam M; Walshe, Janice M; Soori, Gamini S; Dakhil, Shaker R; Seay, Thomas E; Wade, James L; McCarron, Edward C; Paik, Soonmyung; Swain, Sandra M; Wickerham, D Lawrence; Wolmark, Norman.
Afiliação
  • Mamounas EP; NRG Oncology/NSABP, Pittsburgh, PA, USA; UF Health Cancer Center at Orlando Health, Orlando, FL, USA. Electronic address: terry.mamounas@orlandohealth.com.
  • Bandos H; NRG Oncology/NSABP, Pittsburgh, PA, USA; University of Pittsburgh, Pittsburgh, PA, USA.
  • Lembersky BC; NRG Oncology/NSABP, Pittsburgh, PA, USA; The University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.
  • Jeong JH; NRG Oncology/NSABP, Pittsburgh, PA, USA; University of Pittsburgh, Pittsburgh, PA, USA.
  • Geyer CE; NRG Oncology/NSABP, Pittsburgh, PA, USA; Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA.
  • Rastogi P; NRG Oncology/NSABP, Pittsburgh, PA, USA; The University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.
  • Fehrenbacher L; NRG Oncology/NSABP, Pittsburgh, PA, USA; Kaiser Permanente Oncology Clinical Trials Northern California, Vallejo, CA, USA.
  • Graham ML; NRG Oncology/NSABP, Pittsburgh, PA, USA; Southeast Cancer Control Consortium, Goldsboro, NC, USA.
  • Chia SK; NRG Oncology/NSABP, Pittsburgh, PA, USA; British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Brufsky AM; NRG Oncology/NSABP, Pittsburgh, PA, USA; The University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.
  • Walshe JM; NRG Oncology/NSABP, Pittsburgh, PA, USA; Cancer Trials Ireland (formerly known as Irish Clinical Oncology Research Group-ICORG), Dublin, Ireland.
  • Soori GS; NRG Oncology/NSABP, Pittsburgh, PA, USA; Cancer Alliance of Nebraska(Missouri Valley Cancer Consortium), Omaha, NE, USA.
  • Dakhil SR; NRG Oncology/NSABP, Pittsburgh, PA, USA; CCCOP, Wichita Cancer Center of Kansas, Wichita, KS, USA.
  • Seay TE; NRG Oncology/NSABP, Pittsburgh, PA, USA; Georgia NCI Community Oncology Research Program, Atlanta, GA, USA.
  • Wade JL; NRG Oncology/NSABP, Pittsburgh, PA, USA; CCOP, Central Illinois, Decatur, IL, USA.
  • McCarron EC; NRG Oncology/NSABP, Pittsburgh, PA, USA; MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore, MD, USA.
  • Paik S; NRG Oncology/NSABP, Pittsburgh, PA, USA; Yonsei University College of Medicine, Seoul, South Korea.
  • Swain SM; NRG Oncology/NSABP, Pittsburgh, PA, USA; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
  • Wickerham DL; NRG Oncology/NSABP, Pittsburgh, PA, USA; Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA.
  • Wolmark N; NRG Oncology/NSABP, Pittsburgh, PA, USA; Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA.
Lancet Oncol ; 20(1): 88-99, 2019 01.
Article em En | MEDLINE | ID: mdl-30509771
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Inibidores da Aromatase / Letrozol Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Inibidores da Aromatase / Letrozol Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article